Dcm Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Dcm Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $435,938 - $587,377	795 New	795 $472,000
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $230,979 - $285,162	-425 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$472.8 - $558.54 $200,940 - $237,379	425 New	425 $237,000
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $393,122 - $482,416	-880 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$478.3 - $607.98 $420,904 - $535,022	880 New	880 $425,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Dcm Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Dcm Advisors, LLC with notifications on news.